CXCR1 and type 1 diabetes mellitus: The relationship between the KC/CXCR1/2 axis and the development of insulitis and type 1 diabetes in mice has been previously established, demonstrating that transient CXCR1/2 inhibition by ladarixin prevents inflammation-mediated islet damage in multiple low-dose streptozotocin mice [24].